ClinicalTrials.Veeva

Menu

Observational Prospective Study of the Predicted Value of Immature Thrombocytes Counts in Three Different Groups of Critically Ill Patients

D

Dr. Yishai Ofran

Status

Unknown

Conditions

Neutropenic Fever Patients
Patients With Hip Fractures
Critically Ill Patients

Treatments

Other: Immature Platelet Fraction

Study type

Observational

Funder types

Other

Identifiers

NCT02016859
IPF-2013-Rambam

Details and patient eligibility

About

Immature Platelet Fraction (IPF) is a new value in CBC blood tests Recent Studies showed that this value may be another prognostic factor in critically ill patients such as those admitted to ICU, or those with neutropenic Fever.

The purpose of the study is to check if the IPF may be used as a prognostic Factor in these patients

Full description

In this study we have 3 groups of patients

  • Patients admitted to ICU
  • Patients admitted with neutropenic fever
  • Patients admitted with hip fractures it is a prospective study, not interventional, we'll take blood samples of these patients including CBC count eith IPF and other inflammation markers such as CRP and we'll compare CRP to IPF in addition to clinical follow-up of the patient till discharge.

At the end of this study we'll compare the efficacy of IPF as a prognostic Factor in these patients

Enrollment

500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Admission to hospital blood sample is taken between 24:00 pm till 15:00 pm

Exclusion criteria

  • blood sample is taken after 15:00 pm in the first day of admission during the week
  • blood sample is taken on weekend: thursday 15:00 pm till saturday 24:00 pm

Trial design

500 participants in 3 patient groups

Critically ill patients admitted to ICU
Description:
those patients who are admitted to ICU with multiorgan failure/injury
Treatment:
Other: Immature Platelet Fraction
Neutropinc Fever patients
Description:
admitted to ER, haemato-oncology or oncology
Treatment:
Other: Immature Platelet Fraction
Patients of Hip's Fracture
Description:
admitted to orthopedic departement
Treatment:
Other: Immature Platelet Fraction

Trial contacts and locations

1

Loading...

Central trial contact

Doaa Okasha, doctor; Yishai Ofran, Doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems